X-71096776-G-A
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_005938.4(FOXO4):c.248G>A(p.Gly83Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000125 in 1,197,552 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005938.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -8 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXO4 | ENST00000374259.8 | c.248G>A | p.Gly83Glu | missense_variant | Exon 1 of 3 | 1 | NM_005938.4 | ENSP00000363377.3 | ||
FOXO4 | ENST00000341558.4 | c.171+77G>A | intron_variant | Intron 1 of 3 | 5 | ENSP00000342209.3 | ||||
FOXO4 | ENST00000466874.1 | n.447+77G>A | intron_variant | Intron 1 of 2 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000446 AC: 5AN: 112149Hom.: 0 Cov.: 23 show subpopulations
GnomAD2 exomes AF: 0.0000929 AC: 14AN: 150671 AF XY: 0.000107 show subpopulations
GnomAD4 exome AF: 0.0000101 AC: 11AN: 1085351Hom.: 0 Cov.: 31 AF XY: 0.00000282 AC XY: 1AN XY: 354013 show subpopulations
GnomAD4 genome AF: 0.0000357 AC: 4AN: 112201Hom.: 0 Cov.: 23 AF XY: 0.0000581 AC XY: 2AN XY: 34395 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.248G>A (p.G83E) alteration is located in exon 1 (coding exon 1) of the FOXO4 gene. This alteration results from a G to A substitution at nucleotide position 248, causing the glycine (G) at amino acid position 83 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at